Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-23,594
Closed -$2.42M 180
2026
Q1
$2.42M Sell
23,594
-36,000
-60% -$3.67M 0.2% 92
2025
Q4
$5.99M Buy
+59,594
New +$5.88M 0.47% 58
2025
Q1
Sell
-52,216
Closed -$4.09M 201
2024
Q4
$4.09M Sell
52,216
-22
-0% -$2.06K 0.56% 53
2024
Q3
$5.34M Sell
52,238
-99,363
-66% -$8.24M 0.75% 34
2024
Q2
$11.5M Buy
151,601
+50,000
+49% +$3.56M 2% 17
2024
Q1
$7.63M Sell
101,601
-156,541
-61% -$12.5M 0.84% 41
2023
Q4
$19M Sell
258,142
-19,892
-7% -$1.23M 1.78% 17
2023
Q3
$12.8M Buy
278,034
+5,282
+2% +$234K 1.54% 16
2023
Q2
$11.5M Buy
+272,752
New +$10.3M 1.83% 15

Other funds holding NUVL

Ikarian Capital's NUVL Position: Q2 2026 in Review

Ikarian Capital sold out of Nuvalent (NUVL) in Q2 2026, closing a stake of 23,594 shares — an estimated $2.42M sold.

Ikarian Capital first reported a position in NUVL in Q2 2023 and held it in 9 quarters. The position peaked at $19M in Q4 2023. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Ikarian Capital reported no remaining Nuvalent position as of Q2 2026 after selling out during the quarter.
  • Ikarian Capital sold 23,594 Nuvalent shares in Q2 2026, an estimated $2.42M.
  • Ikarian Capital first reported a position in Nuvalent in Q2 2023 and held it in 9 quarters.
  • Ikarian Capital's Nuvalent position peaked at $19M in Q4 2023.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.